Publications by authors named "J M Moser"

Neuroendocrine and tuft cells are rare, chemosensory epithelial lineages defined by expression of ASCL1 and POU2F3 transcription factors, respectively. Neuroendocrine cancers, including small cell lung cancer (SCLC), frequently display tuft-like subsets, a feature linked to poor patient outcomes. The mechanisms driving neuroendocrine-tuft tumour heterogeneity, and the origins of tuft-like cancers are unknown.

View Article and Find Full Text PDF

Predictive coding theories propose that the brain constantly updates internal models to minimize prediction errors and optimize sensory processing. However, the neural mechanisms that link prediction error encoding and optimization of sensory representations remain unclear. Here, we provide evidence how predictive learning shapes the representational geometry of the human brain.

View Article and Find Full Text PDF

Male SARS-CoV-2-infected patients have higher hospitalization rates, ICU admissions, and mortality compared to females, yet with unclear underlying mechanisms. We investigated the influence of biological sex on COVID-19 severity and patient outcomes. We profiled 41 circulating host response markers and identified differentially regulated proteins based on disease severity using covariates, such as sex, age, BMI, diabetes, and corticosteroid administration.

View Article and Find Full Text PDF

Cardiovascular diseases rank as the top global cause of mortality, particularly acute myocardial infarction (MI). MI arises from the blockage of a coronary artery, which disrupts blood flow and results in tissue death. Among therapeutic approaches, bioactives from medicinal plants emerge as promising for the development of new medicines.

View Article and Find Full Text PDF
Article Synopsis
  • Combination immune checkpoint blockade targeting PD-1 and CTLA-4 shows lower efficacy in acral lentiginous melanoma (ALM) compared to cutaneous melanoma (CM), with an objective response rate of only 18.3%.
  • In a study of 109 patients, most had advanced cancer (stage IV), with median progression-free survival of 4.2 months and overall survival of 17 months.
  • Significant treatment-related adverse events were common, indicating similar toxicity levels, but specific demographic factors like Asian ethnicity were linked to worse overall survival, highlighting the need for new treatment strategies for ALM.
View Article and Find Full Text PDF